BioCorRx (BICX) Amortization of Deferred Charges (2024 - 2025)

BioCorRx has reported Amortization of Deferred Charges for 4 years, with the latest figure at $1877.0 in Q4 2025.

• Quarterly Amortization of Deferred Charges fell 98.15% year-over-year to $1877.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4540.0 (down 99.3% YoY) and the FY2025 annual result came in at $55738.0, down 91.03% from the prior year.
• Amortization of Deferred Charges slipped to $1877.0 in Q4 2025 per BICX's latest filing, from $34232.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $476539.0 in Q3 2024 and troughed at -$31569.0 in Q2 2025.
• A 4-year average of $67695.3 and a median of $30955.0 in 2023 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2024 and 2025: Amortization of Deferred Charges jumped 1403.61% in 2024, then tumbled 289.92% in 2025.
• Over 4 years, Amortization of Deferred Charges stood at $29667.0 in 2022, then surged by 170.25% to $80176.0 in 2023, then advanced by 26.88% to $101725.0 in 2024, then slumped by 98.15% to $1877.0 in 2025.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $1877.0, $34232.0, and -$31569.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.